Literature DB >> 13084575

The purine metabolism of a 6-mercaptopurine-resistant Lactobacillus casei.

G B ELION, S SINGER, G H HITCHINGS.   

Abstract

Entities:  

Keywords:  LACTOBACILLUS; PURINES/metabolism

Mesh：

Substances：

Year:  1953        PMID： 13084575

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  12 in total

1.  The effect of 6-mercaptopurine on primary and secondary immune responses.

Authors:  R SCHWARTZ; A EISNER; W DAMESHEK
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  The biosynthesis and interconversion of purines and their derivatives.

Authors:  A G MOAT; H FRIEDMAN
Journal:  Bacteriol Rev       Date:  1960-09

3.  Studies on 4-aminopyrazolo(3, 4-d)pyrimidine: growth inhibition and relief in Neurospora crassa.

Authors:  R FUERST; T C HSU; C E SOMERS
Journal:  J Bacteriol       Date:  1956-09       Impact factor: 3.490

4.  Studies on the biosynthesis of riboflavin. 2. Further observations on nitrogen metabolism and flavinogenesis in Eremothecium ashbyii.

Authors:  E G BROWN; T W GOODWIN; S PENDLINGTON
Journal:  Biochem J       Date:  1955-09       Impact factor: 3.857

5.  Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy.

Authors:  G B Elion
Journal:  In Vitro Cell Dev Biol       Date:  1989-04

6.  Lymphocyte trapping in dog popliteal lymph nodes: the influence of acute uremia and pharmacologic immunosuppression.

Authors:  J D Jenkins; W M Stahl
Journal:  Ann Surg       Date:  1968-01       Impact factor: 12.969

Review 7.  Pancreatic islet transplantation: toward definitive treatment for diabetes mellitus.

Authors:  Tadashi Takaki; Masayuki Shimoda
Journal:  Glob Health Med       Date:  2020-08-31

8.  The structure-activity relationships of the antiviral chemotherapeutic activity of isatin beta-thiosemicarbazone.

Authors:  D J BAUER; P W SADLER
Journal:  Br J Pharmacol Chemother       Date:  1960-03

9.  Azathioprine and 6-mercaptopurine (6-MP) suppress the human mixed lymphocyte reaction (MLR) by different mechanisms.

Authors:  S A Al-Safi; J L Maddocks
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

10.  Combined epigenetic and metabolic treatments overcome differentiation blockade in acute myeloid leukemia.

Authors:  Barry M Zee; Kamrine E Poels; Cong-Hui Yao; Kimihito C Kawabata; Gongwei Wu; Cihangir Duy; William D Jacobus; Elizabeth Senior; Jennifer E Endress; Ashwini Jambhekar; Scott B Lovitch; Jiexian Ma; Abhinav Dhall; Isaac S Harris; M Andres Blanco; David B Sykes; Jonathan D Licht; David M Weinstock; Ari Melnick; Marcia C Haigis; Franziska Michor; Yang Shi
Journal:  iScience       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.